XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Operating Profit

Annual Operating Profit:

-$33.65M+$10.36M(+23.55%)
December 31, 2024

Summary

  • As of today, XERS annual operating income is -$33.65 million, with the most recent change of +$10.36 million (+23.55%) on December 31, 2024.
  • During the last 3 years, XERS annual operating profit has risen by +$81.51 million (+70.78%).
  • XERS annual operating profit is now -154.30% below its all-time high of -$13.23 million, reached on December 31, 2016.

Performance

XERS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Quarterly Operating Profit:

$4.48M+$7.57M(+245.05%)
June 30, 2025

Summary

  • As of today, XERS quarterly operating income is $4.48 million, with the most recent change of +$7.57 million (+245.05%) on June 30, 2025.
  • Over the past year, XERS quarterly operating profit has increased by +$12.67 million (+154.75%).
  • XERS quarterly operating profit is now at all-time high.

Performance

XERS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM Operating Profit:

-$9.82M+$12.67M(+56.33%)
June 30, 2025

Summary

  • As of today, XERS TTM operating income is -$9.82 million, with the most recent change of +$12.67 million (+56.33%) on June 30, 2025.
  • Over the past year, XERS TTM operating profit has increased by +$27.36 million (+73.59%).
  • XERS TTM operating profit is now -111.27% below its all-time high of -$4.65 million, reached on March 31, 2017.

Performance

XERS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

XERS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+23.6%+154.8%+73.6%
3Y3 Years+70.8%+123.7%+91.9%
5Y5 Years+72.5%+120.2%+89.9%

XERS Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+70.8%at high+123.9%at high+91.5%
5Y5-Yearat high+72.5%at high+109.3%at high+92.3%
All-TimeAll-Time-154.3%+72.5%at high+109.3%-111.3%+92.3%

XERS Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.48M(+245.0%)
-$9.82M(+56.3%)
Mar 2025
-
-$3.09M(-284.0%)
-$22.49M(+33.2%)
Dec 2024
-$33.65M(+23.5%)
$1.68M(+113.0%)
-$33.65M(+25.5%)
Sep 2024
-
-$12.89M(-57.5%)
-$45.17M(-21.5%)
Jun 2024
-
-$8.19M(+42.5%)
-$37.19M(+17.3%)
Mar 2024
-
-$14.24M(-44.8%)
-$44.98M(-2.2%)
Dec 2023
-$44.01M(+46.3%)
-$9.84M(-100.3%)
-$44.01M(+10.8%)
Sep 2023
-
-$4.91M(+69.3%)
-$49.34M(+21.9%)
Jun 2023
-
-$15.98M(-20.4%)
-$63.21M(+4.4%)
Mar 2023
-
-$13.28M(+12.5%)
-$66.14M(+19.3%)
Dec 2022
-$81.94M(+28.8%)
-$15.17M(+19.2%)
-$81.94M(+28.8%)
Sep 2022
-
-$18.78M(+0.7%)
-$115.04M(+4.6%)
Jun 2022
-
-$18.92M(+34.9%)
-$120.62M(+5.4%)
Mar 2022
-
-$29.07M(+39.8%)
-$127.49M(-10.7%)
Dec 2021
-$115.16M
-$48.27M(-98.2%)
-$115.16M(-33.5%)
Sep 2021
-
-$24.36M(+5.5%)
-$86.23M(-14.0%)
Jun 2021
-
-$25.79M(-54.0%)
-$75.61M(-5.0%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$16.74M(+13.5%)
-$72.03M(+13.8%)
Dec 2020
-$83.55M(+31.7%)
-$19.34M(-40.7%)
-$83.55M(+13.9%)
Sep 2020
-
-$13.74M(+38.1%)
-$97.00M(+14.4%)
Jun 2020
-
-$22.20M(+21.4%)
-$113.34M(+9.5%)
Mar 2020
-
-$28.25M(+13.9%)
-$125.20M(-2.3%)
Dec 2019
-$122.38M(-106.2%)
-$32.80M(-9.0%)
-$122.38M(-11.4%)
Sep 2019
-
-$30.08M(+11.7%)
-$109.89M(-16.0%)
Jun 2019
-
-$34.06M(-33.9%)
-$94.75M(-29.7%)
Mar 2019
-
-$25.44M(-25.2%)
-$73.05M(-23.1%)
Dec 2018
-$59.34M(-122.9%)
-$20.31M(-35.9%)
-$59.34M(-23.0%)
Sep 2018
-
-$14.94M(-20.9%)
-$48.24M(-18.0%)
Jun 2018
-
-$12.36M(-5.3%)
-$40.87M(-43.3%)
Mar 2018
-
-$11.73M(-27.4%)
-$28.51M(-33.0%)
Dec 2017
-$26.63M(-101.3%)
-$9.21M(-21.6%)
-$21.43M(-75.4%)
Sep 2017
-
-$7.57M(-62.9%)
-$12.22M(-162.9%)
Mar 2017
-
-$4.65M
-$4.65M
Dec 2016
-$13.23M
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual operating income?
  • What is the all-time high annual operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual operating profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly operating profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM operating profit year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual operating income?

The current annual operating profit of XERS is -$33.65M

What is the all-time high annual operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual operating income is -$13.23M

What is Xeris Biopharma Holdings, Inc. annual operating profit year-on-year change?

Over the past year, XERS annual operating income has changed by +$10.36M (+23.55%)

What is Xeris Biopharma Holdings, Inc. quarterly operating income?

The current quarterly operating profit of XERS is $4.48M

What is the all-time high quarterly operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly operating income is $4.48M

What is Xeris Biopharma Holdings, Inc. quarterly operating profit year-on-year change?

Over the past year, XERS quarterly operating income has changed by +$12.67M (+154.75%)

What is Xeris Biopharma Holdings, Inc. TTM operating income?

The current TTM operating profit of XERS is -$9.82M

What is the all-time high TTM operating profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM operating income is -$4.65M

What is Xeris Biopharma Holdings, Inc. TTM operating profit year-on-year change?

Over the past year, XERS TTM operating income has changed by +$27.36M (+73.59%)
On this page